Johnson & Johnson MedTech announced that its Vision unit made the Tecnis PureSee lens available in the EMEA region.
Tecnis PureSee is a purely refractive, presbyopia-correcting intraocular lens (IOL). It features a proprietary design aimed at delivering uninterrupted, high-quality vision. Johnson & Johnson says it offers high best-in-category contrast and low-light performance compared to a monofocal IOL.
According to a news release, current lenses require patients to make trade-off decisions. Some lenses offer clear sight at all distances without spectacles but might lead to glares and halos. J&J said Tecnis PureSee combats those issues and improves overall outcomes for both patients and surgeons.
“Cataract surgery is the number one surgery performed globally, with 28 million procedures each year. But only 10-15% of patients are getting advanced optical IOLs specifically designed for astigmatism and presbyopia,” said Jacqueline Henderson, president, Vision, EMEA, Johnson & Johnson. “Today, we’re proud to launch the Tecnis PureSee IOL, giving surgeons and patients the choice of a premium IOL that combines clarity of vision and reduced visual symptom.”
The Tecnis PureSee IOL ensures ease of use for surgeons in providing high tolerance to refractive error. It provides uninterrupted, high-quality vision, with excellent distance and intermediate vision, J&J says. Its dysphotopsia profile has comparability to a monofocal IOL in frequency, bothersome and difficulty levels, the company says. That means little to no visual symptoms, like halos, glares and starbursts.
J&J made its TECNIS PureSee IOL now available now in select markets in EMEA.